STRI Obtained a Patent for Cartilage Cell Differentiation Technique using nEPS (newly Elicited Pluripotent Stem Cell without side effects) in the United States.
STRI registered a patent of a newly elicited pluripotent stem cell without side effects in America.
STRI (Stem Cell Treatment & Research Institute) under bBHC identified the regeneration of dopaminergic neurons through stem cells.
bBHC, “Stem Cell Therapy helps alleviate the symptoms of Parkinson’s disease”
STRI (Stem Cell Treatment & Research Institute) under bBHC achieved positive results in their treatment using stem cells
bBHC took a step closer to the fundamental cause of Parkinson’s Disease through stem cell treatment.
STRI (Stem Cell Treatment & Research Institute) under bBHC achieved positive results in their treatment using stem cells
STRI, US Patent Registration of the Nerve Cell Differentiation Technology using nEPS (newly Elicited Pluripotent Stem Cell without Side Effects)
STRI, US Patent Registration of the Nerve Cell Differentiation Technology using nEPS (newly Elicited Pluripotent Stem Cell without Side Effects)
bBHC ‘STRI’, US Patent Registration Regarding Nerve Cell Differentiation using Newly Elicited Pluripotent Stem Cell without Side Effects by Natural Compounds (nEPS)
